Latest News
Featured News
Results of 2025 Annual General Meeting
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Update on Final Results
Scancell to present at the 2023 World Vaccine Congress Europe
Block Listing Six Monthly Return
Change of Date for Final Results and Investor Presentation
Notice of Final Results and Investor Presentation
Scancell announces positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection for advanced melanoma
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.